Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-03-22, Stock:JNJ, The news for the past five days is as follows:
2021-03-15: NEWS1: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS2: Lifted COVID-19 restrictions becoming ’problematic’ for airline workers: AFA President.NEWS3: Vaccine hesitation could cause ‘back-sliding’ in COVID-19 progress: Expert.NEWS4: J&J (JNJ) COVID-19 Vaccine Gets WHO's Emergency Listing.NEWS5: Novavax's (NVAX) COVID-19 Vaccine Shows Final Efficacy of 96.4%.NEWS6: UPDATE 3-Takeda grants J&J German production capacity for COVID-19 shot.NEWS7: Johnson & Johnson’s Single-Dose COVID-19 Vaccine Granted Emergency Use Listing By WHO.
2021-03-16: NEWS1: States prep for COVID-19 vaccines for all adults in May if promised supplies arrive.NEWS2: Enseo technology makes staying in a hotel contactless amid pandemic.NEWS3: 59% of small businesses say health of economy is poor: U.S. Chamber of Commerce.NEWS4: The COVID-19 rescue plan ‘isn’t nearly enough’ for the housing sector: NAA CEO.NEWS5: Is Johnson & Johnson (JNJ) Stock A Buy or Sell?.NEWS6: Moderna starts COVID-19 vaccine candidate testing on children, as U.S. cases and deaths tick up.NEWS7: UPDATE 1-South Africa approves Pfizer-BioNTech COVID vaccine for emergency use.NEWS8: J&J (JNJ) Outperforms the Industry Year to Date: Here's Why.NEWS9: The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study.NEWS10: Moderna Begins Testing Covid-19 Vaccine In Children.NEWS11: European Commission to accelerate delivery of 10 million doses from Pfizer and BioNTech.
2021-03-17: NEWS1: Jackbox CEO on post-pandemic outlook: ‘The future looks really bright’ .NEWS2: COVID-19 variants are ‘nothing to get overly worried about’: Doctor.NEWS3: COVID-19 vaccines get an endorsement from Trump, as daily U.S. deaths rise back above 1,000.NEWS4: This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock.NEWS5: UPDATE 2-Catalent to ramp up J&J vaccine production at Italian plant.NEWS6: More States Open Vaccinations to All.NEWS7: COVAX vaccine-sharing scheme to send out 'hundreds of millions' of J&J shots.NEWS8: Is Novavax Stock A Buy On Its Leading Covid Vaccine Effectiveness?.NEWS9: AstraZeneca's COVID-19 Vaccine Has No Efficacy Against South African Virus Strain, Study Shows.
2021-03-18: NEWS1: U.S. set to reach 100M vaccinations six weeks early.NEWS2: There's Always Room for This Blue Chip in Your Portfolio.NEWS3: AstraZeneca benefits outweigh risks: UK drugs regulator.NEWS4: J&J developing several next-generation COVID-19 vaccines, says CEO.NEWS5: Rapid Vaccination to Boost These 4 Healthcare Mutual Funds.NEWS6: EU threat of tougher vaccine export controls backed by heavyweight governments.NEWS7: Moderna's Latest Move May be Key to COVID-19 Vaccine Market Dominance.
2021-03-19: NEWS1: What Scott Gottlieb Thinks About The Heated Exchange Between Anthony Fauci And Rand Paul.NEWS2: Biden’s vaccine goal was not a ‘moonshot challenge’: Analyst.NEWS3: Janssen's Ponvory Wins FDA Nod For Relapsing Multiple Sclerosis.NEWS4: UPDATE 2-U.S. FDA approves J&J's multiple sclerosis treatment; launch in April.NEWS5: Biden Administration Nears Goal of Administering 100 Million Vaccines.NEWS6: Could a Supply Glut Sink COVID Vaccine Stocks?.

Answer: Rise